AGC Inc., a Tokyo-based world-leading manufacturer of glass, chemicals and high-tech materials, announced on December 13 that it has developed anti-glare (AG) glass for 4K high-definition...

The Asia Pacific Literary Festival (APLF), 2022 hosted by Alliance University's School of Liberal Arts, in association with Asia Pacific Writers & Translators Inc (APWT), came to a grand finale on...

From October 18th to 20th, Hive Box presents its latest solutions at Parcel + Post Expo in Frankfurt am Main, Germany, the leading global event for parcel delivery, e-commerce logistics and postal...

New pilot programs demonstrate Hyundai Motor Group's new Plug & Drive (PnD)-based robots with integrated autonomous driving technology and Group insights Pilot service at Rolling Hills Hotel uses...

Researchers share new findings on caring for preterm babies, children with cancer, and young people with sickle cell disease NEW ORLEANS, Dec. 12, 2022 /PRNewswire/ -- New research being presented...

IDEOlogy Health, a multi-channel medical education company, announced today it will attend the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on January 9th through January 12th, 2023.

CirrusMD, a leading provider of on-demand virtual primary care, today announced that it will unveil new Spanish language support as an exhibitor at the combined Texas and Dallas-Fort Worth...

Updated analyses report on progression-free survival, minimal residual disease negativity, overall response and overall survival across patient types, regardless of age or cytogenetic risk...

Nu Skin Enterprises (NYSE: NUS), a leader in beauty and wellness, today announced its participation in this week's 76th Annual Scientific Meeting & Showcase of the Society of Cosmetic Chemists in...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the company...

Loc Performance, a leading provider of track systems for military, industrial and agricultural applications, today announced its participation in the John Deere dealer Parts Expo at the George R...

Ichnos presentations include clinical and preclinical data on ISB 1342 (CD38xCD3), ISB 1442 (CD38xCD47) and an oral session on ISB 2001, its first TREAT™ trispecific (BCMAxCD38xCD3) antibody NEW...

Green Hills Software, the worldwide leader in embedded safety and security and a member of RISC-V International, will present at the RISC-V Summit. Green Hills Software will participate in a panel...

Boasting the Fastest OLED Performance of Any UltraGear Models, Company's New 27-inch and 45-inch Monitors Deliver Next-level Gaming Immersion U.S. Pre-Order at LG.com Begins Today Featuring Free...

– Freenome's comprehensive multiomics and multi-feature computational approach provides insights for therapy development and patient efficacy SOUTH SAN FRANCISCO, Calif., Dec. 12, 2022...

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that...

Inobrodib is an oral drug showing good long-term tolerability at the recommended phase 2 dose as monotherapy Objective responses have been observed in heavily pre-treated relapsed / refractory...

Four oral presentations presented at ASH highlight data evaluating investigational epcoritamab for the treatment of relapsed/refractory (R/R) follicular lymphoma, previously untreated follicular...

Data demonstrate that a non-viral, liver-directed gene therapy utilizing Super piggyBac® (SPB) DNA Modification System achieved and maintained normalized human FVIII (hFVIII) activity following a...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology,...

BCMA/CD19 dual-targeting FasTCAR-T GC012F data from ongoing clinical trial presented at 64th American Society of Hematology Annual Meeting and Exposition SAN DIEGO and SUZHOU and SHANGHAI, China,...

- 30% CR/CRh rate in efficacy evaluable population; 27% CR/CRh rate observed in both mNPM1 and KMT2Ar (MLLr) R/R acute leukemia patients treated at RP2D - - 9 of 12 patients who underwent stem...

Exploratory analysis from Cohort 3 of the Phase 2 REFINE study presented in an oral session at ASH NORTH CHICAGO, Ill., Dec. 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new data...

Updated data presented at ASH include CAPTIVATE and GLOW studies and real-world evidence abstracts NORTH CHICAGO, Ill., Dec. 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new and...

Long-term data from the pivotal HOPE-B study show a one-time infusion of HEMGENIX generated elevated and sustained mean factor IX levels and reduced the rate of annual bleeding 24-month results...